Pando Nutrition Inc.

Pando Nutrition Inc. is an animal microbiome company that develops feed additive solutions to improve livestock growth and enhance sustainability. The company's proprietary technology MicroMethane leverages CRISPR technology to genetically engineer probiotics that enhance digestive efficiency and animal health probiotics by optimizing the cattle microbiome. This technology claims to reduce methane emissions by 50% and feed costs by 30% while eliminating the need for antibiotics. 

Furthermore, in November 2023, Pando Nutrition conducted its first poultry study to validate its Panzyme technology, a genetically engineered yeast probiotic designed to replace antibiotic growth promoters in livestock production. The study demonstrated that Panzyme significantly outperformed non-engineered yeast and a premium growth-promoting enzyme.

Key customers and partnerships

The company collaborates with technology partners, including the US Department of Agriculture (USDA), to expand its platform and further develop its solutions.

Funding and financials

As of May 2024, Pando Nutrition had raised a total of USD 435,000 in funding backed by investors such as IndieBio and SOSV.